3.8 Article

Access challenges to opioid use disorder treatment among individuals experiencing homelessness: Voices from the streets

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Psychology, Developmental

Ambivalence and Stigma Beliefs About Medication Treatment Among Young Adults With Opioid Use Disorder: A Qualitative Exploration of Young Adults? Perspectives

Sarah M. Bagley et al.

Summary: The purpose of this study is to explore the beliefs and attitudes about medication for opioid use disorder (MOUD) among young adults with opioid use disorder (OUD). Through a qualitative study of 20 young adults in treatment for OUD, the researchers found that participants perceived MOUD as stigmatizing but also held ambivalent attitudes and expectations towards MOUD, seeing it as a means to reduce risk and achieve full recovery.

JOURNAL OF ADOLESCENT HEALTH (2023)

Article Psychology, Clinical

Experiences of racial discrimination in the medical setting and associations with medical mistrust and expectations of care among black patients seeking addiction treatment

O. Trent Hall et al.

Summary: This study shows that Black patients seeking addiction treatment commonly experience racial discrimination by healthcare workers. This racial discrimination may lead to mistrust in the medical system and negative expectations regarding addiction treatment.

JOURNAL OF SUBSTANCE ABUSE TREATMENT (2022)

Article Public, Environmental & Occupational Health

Treatment Outcomes Among Black Adults Receiving Medication for Opioid Use Disorder

Anna Beth Parlier-Ahmad et al.

Summary: Black individuals with opioid use disorder (OUD) experience worse outcomes compared to their White counterparts due to structural racism, but when provided with high-quality treatment, they demonstrate positive results. Factors such as older age and absence of injection opioid use history are significant predictors of treatment retention and buprenorphine continuation among Black adults with OUD. Addressing structural racism and implementing culturally informed treatment interventions are crucial to improve access to high-quality care for this community.

JOURNAL OF RACIAL AND ETHNIC HEALTH DISPARITIES (2022)

Article Substance Abuse

I wanted something that was more flexible: A qualitative study of patient preferences on choosing buprenorphine over methadone in a large, safety-net hospital opioid treatment program

Laura Checkley et al.

Summary: The study found that patients in an urban hospital-based opioid treatment program chose buprenorphine over methadone primarily due to increased flexibility, decreased sedation, and greater effectiveness in preventing opioid use. However, some patients also encountered challenges during the transition to buprenorphine.

SUBSTANCE ABUSE (2022)

Article Medicine, General & Internal

Perspectives About Emergency Department Care Encounters Among Adults With Opioid Use Disorder

Kathryn Hawk et al.

Summary: This qualitative study examined the experiences and perspectives of US patients with untreated OUD who sought treatment in emergency departments (EDs). The findings showed that these patients often felt stigmatized and minimized in the ED, highlighting the need for improvement in care and access to treatment.

JAMA NETWORK OPEN (2022)

Article Medicine, General & Internal

Disparities by Sex and Race and Ethnicity in Death Rates Due to Opioid Overdose Among Adults 55 Years or Older, 1999 to 2019

Maryann Mason et al.

Summary: This study analyzed the variation in opioid overdose death rates among older adults by sex and race and ethnicity over time. The findings revealed that the burden of opioid overdose deaths among older adults since 2013 was most significant among non-Hispanic Black men. Further research is needed to inform policy and practice.

JAMA NETWORK OPEN (2022)

Article Psychology, Clinical

Racial/ethnic disparities in the availability of hospital based opioid use disorder treatment

Ji Eun Chang et al.

Summary: This study explores the relationship between hospital-based OUD services and the racial/ethnic composition of the surrounding community. The findings indicate that hospitals in communities with a high percentage of Black or Hispanic residents are less likely to offer common OUD programs, even after controlling for various factors.

JOURNAL OF SUBSTANCE ABUSE TREATMENT (2022)

Review Substance Abuse

The Impact of Stigma on People with Opioid Use Disorder, Opioid Treatment, and Policy

Ali Cheetham et al.

Summary: Illicit drug use disorders are highly stigmatized worldwide, hindering treatment entry and provision. This review examines the impact of opioid-related stigma on treatment and harm reduction, and offers strategies to reduce stigma at various levels. Addressing inequities in laws and regulations that segregate individuals with substance use disorders is crucial for stigma reduction.

SUBSTANCE ABUSE AND REHABILITATION (2022)

Article Medicine, General & Internal

Racial and Ethnic Disparities in Buprenorphine and Extended-Release Naltrexone Filled Prescriptions During the COVID-19 Pandemic

Thuy Nguyen et al.

Summary: This study found that the COVID-19 pandemic resulted in a decrease in filled buprenorphine prescriptions for members of racial and ethnic minority groups, but not for White individuals. These findings suggest that members of racial and ethnic minority groups experienced greater loss in access to buprenorphine during the pandemic across different payer types.

JAMA NETWORK OPEN (2022)

Article Psychology, Clinical

?You have to take this medication, but then you get punished for taking it:? lack of agency, choice, and fear of medications to treat opioid use disorder across the perinatal period

Davida M. Schiff et al.

Summary: This study explores the factors, facilitators, and barriers to medication use and adherence in treating opioid use disorder (MOUD) during pregnancy and the postpartum period. Four main barriers are identified: lack of agency and autonomy, hesitancy to use MOUD to minimize withdrawal symptoms in newborns, concerns about losing custody, and dissatisfaction with treatment environments. The study provides recommendations for intervention, including improving shared decision-making and providing gender-responsive care.

JOURNAL OF SUBSTANCE ABUSE TREATMENT (2022)

Article Psychology, Clinical

Accessibility of substance use treatment: A qualitative study from the non-service users' perspective

Laura Caris et al.

Summary: This study conducted in the Netherlands highlighted the barriers to and facilitators of accessibility to substance use treatment for non-service users with substance use disorders. Key findings include the impact of personal factors, social support, stigmatization, and knowledge deficits on whether individuals access substance use treatment. Recommendations for interventions targeting health care professionals were also provided to improve access to health care services for those with substance use disorders.

JOURNAL OF SUBSTANCE ABUSE TREATMENT (2022)

Article Public, Environmental & Occupational Health

Vital Signs: Drug Overdose Deaths, by Selected Sociodemographic and Social Determinants of Health Characteristics — 25 States and the District of Columbia, 2019–2020

Mbabazi Kariisa et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)

Article Psychology, Clinical

Barriers to accessing treatment for substance use after inpatient managed withdrawal (Detox): A qualitative study

Allison R. David et al.

Summary: Access to and uptake of evidence-based treatment for substance use disorder, specifically opioid use disorder (OUD), are limited in the US. This study explores patients' perspectives on challenges to transition to treatment after detox and potential solutions. The barriers identified include lack of continuity of care, limited treatment program beds, unstable housing, and lack of treatment options. Proposed solutions include increasing low-barrier access to community-based treatment, adding case managers at detox centers, providing housing assistance, and encouraging patient participation in treatment decisions.

JOURNAL OF SUBSTANCE ABUSE TREATMENT (2022)

Review Health Care Sciences & Services

Smartphone Ownership, Smartphone Utilization, and Interest in Using Mental Health Apps to Address Substance Use Disorders: Literature Review and Cross-sectional Survey Study Across Two Sites

Michael Hsu et al.

Summary: Prior studies showed that mobile phone ownership among individuals with substance use disorders ranged from 83% to 94%, while smartphone ownership ranged from 57% to 94%. The results of this study indicated high mobile phone ownership (96%) and smartphone ownership (92%) among participants. Although most patients reported currently using apps on their phones, a minority had used apps for mental health purposes. Most participants felt at least neutrally comfortable with mental health apps gathering personal information.

JMIR FORMATIVE RESEARCH (2022)

Review Substance Abuse

The impact of COVID-19 on healthcare delivery for people who use opioids: a scoping review

Karen Alexander et al.

Summary: The COVID-19 pandemic has negatively impacted healthcare delivery for people who use opioids, leading to service gaps and difficulty accessing treatment for new patients. However, telehealth initiation of buprenorphine has increased access to treatment, though racial disparities in overdose rates are intensifying. Further research is needed to support subgroups of PWUO at heightened risk.

SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY (2021)

Article Substance Abuse

Racial inequity in medication treatment for opioid use disorder: Exploring potential facilitators and barriers to use

Mara A. G. Hollander et al.

Summary: Despite evidence showing that using evidence-based medications for Opioid Use Disorder (MOUD) can lower mortality risk, only 20% of individuals with OUD receive MOUD. Black patients are less likely than White patients to initiate MOUD. Various factors such as criminal justice and human services were measured in relation to MOUD initiation disparities by race, with mediators explaining around one-fifth of the variation in initiation related to race.

DRUG AND ALCOHOL DEPENDENCE (2021)

Article Public, Environmental & Occupational Health

Growing racial/ethnic disparities in overdose mortality before and during the COVID-19 pandemic in California

Joseph Friedman et al.

Summary: During the COVID-19 pandemic, overdose mortality rates have surged, with all racial/ethnic groups surpassing expected trends. Particularly concerning is the rapid increase in overdose mortality rates in Black and Latinx communities. In California, Black individuals saw a higher overdose mortality rate compared to White individuals, reflecting a growing disparity that calls for increased attention and investment in addressing racial disparities in substance use treatment and harm reduction.

PREVENTIVE MEDICINE (2021)

Article Psychology, Clinical

Attitudes toward opioid use disorder pharmacotherapy among recovery community center attendees

Lauren A. Hoffman et al.

Summary: Despite proven efficacy, medications for opioid use disorder (MOUD) are underutilized, but rapidly expanding recovery community centers (RCCs) may offer a promising venue for fostering MOUD support. Positive attitudes towards MOUD were prevalent among RCC attendees, with several factors identified as unique predictors of these attitudes, suggesting opportunities for facilitating MOUD acceptance within and beyond the RCC network.

JOURNAL OF SUBSTANCE ABUSE TREATMENT (2021)

Article Public, Environmental & Occupational Health

Disparities in Opioid Overdose Death Trends by Race/Ethnicity, 2018-2019, From the HEALing Communities Study

Marc R. Larochelle et al.

Summary: The study found that opioid overdose death rates remained stable from 2018 to 2019 across 67 HEALing Communities Study communities, with a significant increase among non-Hispanic Black individuals. An anti-racist public health approach is needed to address this crisis of opioid-related harms.

AMERICAN JOURNAL OF PUBLIC HEALTH (2021)

Review Substance Abuse

Intervention Stigma toward Medications for Opioid Use Disorder: A Systematic Review

Erin Fanning Madden et al.

Summary: This study conducted a systematic review on prejudice and discrimination toward medications for opioid use disorder (MOUD), highlighting how intervention stigma influences healthcare providers, peer patients, and the general public's perceptions of methadone and buprenorphine. It also points out the need for further research on reducing intervention stigma toward MOUD to improve access to care and reduce patient barriers.

SUBSTANCE USE & MISUSE (2021)

Letter Psychology, Clinical

Using telehealth to improve buprenorphine access during and after COVID-19: A rapid response initiative in Rhode Island

Seth A. Clark et al.

Summary: Buprenorphine is underutilized for opioid use disorder management due to treatment initiation barriers, which have been exacerbated during the COVID-19 pandemic. Regulatory changes allowing for telehealth encounters for new buprenorphine prescriptions aim to address this issue and expand access to treatment.

JOURNAL OF SUBSTANCE ABUSE TREATMENT (2021)

Article Computer Science, Information Systems

Telemedicine and healthcare disparities: a cohort study in a large healthcare system in New York City during COVID-19

Rumi Chunara et al.

Summary: While Black patients have lower adjusted odds of accessing care through telemedicine compared to white patients, there is an increasing uptake of telemedicine by young, female Black patients. Additionally, Black telemedicine patients are more likely to receive a COVID diagnosis compared to white patients. Income and household size of a zip code are significantly related to telemedicine use.

JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2021)

Article Substance Abuse

Anti-racism and substance use treatment: Addiction does not discriminate, but do we?

Sara Matsuzaka et al.

JOURNAL OF ETHNICITY IN SUBSTANCE ABUSE (2020)

Article Substance Abuse

Case report: Successful induction of buprenorphine/naloxone using a microdosing schedule and assertive outreach

Jennifer Rozylo et al.

ADDICTION SCIENCE & CLINICAL PRACTICE (2020)

Letter Psychiatry

Buprenorphine Treatment Divide by Race/Ethnicity and Payment

Pooja A. Lagisetty et al.

JAMA PSYCHIATRY (2019)

Review Medicine, General & Internal

Life Expectancy and Mortality Rates in the United States, 1959-2017

Steven H. Woolf et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)

Article Substance Abuse

I didn't want to be on Suboxone at first... - Ambivalence in Perinatal Substance Use Treatment

Bayla Ostrach et al.

JOURNAL OF ADDICTION MEDICINE (2019)

Article Substance Abuse

Everything is not right anymore: Buprenorphine experiences in an era of illicit fentanyl

Sydney M. Silverstein et al.

INTERNATIONAL JOURNAL OF DRUG POLICY (2019)

Article Substance Abuse

At the Expense of a Life: Race, Class, and the Meaning of Buprenorphine in Pharmaceuticalized Care

Alexandrea E. Hatcher et al.

SUBSTANCE USE & MISUSE (2018)

Review Medicine, General & Internal

Management of opioid use disorders: a national clinical practice guideline

Julie Bruneau et al.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2018)

Article Substance Abuse

Patient Perspectives on Choosing Buprenorphine Over Methadone in an Urban, Equal-Access System

Jan Gryczynski et al.

AMERICAN JOURNAL ON ADDICTIONS (2013)

Review Anesthesiology

Current Knowledge of Buprenorphine and Its Unique Pharmacological Profile

Joseph Pergolizzi et al.

PAIN PRACTICE (2010)

Article Substance Abuse

Why don't out-of-treatment individuals enter methadone treatment programmes?

James A. Peterson et al.

INTERNATIONAL JOURNAL OF DRUG POLICY (2010)